Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. (Q45990556)
Jump to navigation
Jump to search
scientific article published on 29 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. |
scientific article published on 29 August 2013 |
Statements
1 reference
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. (English)
1 reference
L Johansson
1 reference
J Bolinder
1 reference
Ö Ljunggren
1 reference
A M Langkilde
1 reference
C D Sjöström
1 reference
J Sugg
1 reference
S Parikh
1 reference
29 August 2013
1 reference
1 reference
16
1 reference
159-169
1 reference
2
1 reference
Identifiers
1 reference
1 reference